Studies

The PCCTC’s trial portfolio represents a substantial proportion of industry-sponsored and NIH-sponsored prostate cancer trials open in the US, characterizing a substantial presence in this research space. Our studies span the entire prostate cancer disease continuum and are strategically aligned with the Consortium’s own pathway-based scientific programs and a parallel commitment to the co-development of trial endpoints and biomarkers. Patient advocacy efforts are supported by Cancer ABCs.

Our Active Study Portfolio

Recent News +++

First-of-its-Kind Study Looks at Link Between Genes and Prostate Cancer

Press Releases by PCCTC August 26, 2021

Researchers from Johns Hopkins University, University of Washington School of Medicine see...

Learn More

Bipolar Androgen Therapy for Patients Who Have Progressed on Abiraterone

Media Relations by PCCTC February 26, 2021

Led by Dr. Samuel R. Denmeade and his team at Johns Hopkins School of Medicine – Sid...

Learn More

PCCTC Germline Genetics Working Group Publishes New Guidelines

Press Releases by PCCTC September 30, 2020

Practical considerations and challenges for germline genetic testing in patients with pros...

Learn More
View More News +

Follow Us

We're pleased to announce the @ThePCCTC/@ANZUPtrials DASL – HiCaP study (Darolutamide Augments Standard Therapy for… https://t.co/ROHdKiEjEw
RT @IRONMANregistry: Maria Parham Medical Center (Duke/LifePoint) is now enrolling patients onto the International Registry for Men With Ad…
RT @blood_pac: Findable, accessible & interoperable #data is crucial for accelerating progress in the #liquidbiopsy field. Working to final…

Join our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…

2018-23944 Clinical Data Manager, Prostate Cancer Clinical Trials Consortium (PCCTC) | Memorial Sloan Kettering Cancer Center Careers

careers.mskcc.org

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.